These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy. Knox RJ; Jenkins TC; Hobbs SM; Chen S; Melton RG; Burke PJ Cancer Res; 2000 Aug; 60(15):4179-86. PubMed ID: 10945627 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor characterization of pyrazolic analogues of the marine pyrroloquinoline alkaloids: wakayin and tsitsikammamines. Legentil L; Benel L; Bertrand V; Lesur B; Delfourne E J Med Chem; 2006 May; 49(10):2979-88. PubMed ID: 16686539 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of some cryptolepine analogues, assessment of their antimalarial and cytotoxic activities, and consideration of their antimalarial mode of action. Onyeibor O; Croft SL; Dodson HI; Feiz-Haddad M; Kendrick H; Millington NJ; Parapini S; Phillips RM; Seville S; Shnyder SD; Taramelli D; Wright CW J Med Chem; 2005 Apr; 48(7):2701-9. PubMed ID: 15801861 [TBL] [Abstract][Full Text] [Related]
5. Total synthesis and antiproliferative activity screening of (+/-)-aplicyanins A, B and E and related analogues. Sísa M; Pla D; Altuna M; Francesch A; Cuevas C; Albericio F; Alvarez M J Med Chem; 2009 Oct; 52(20):6217-23. PubMed ID: 19827832 [TBL] [Abstract][Full Text] [Related]
6. Novel lavendamycin analogues as antitumor agents: synthesis, in vitro cytotoxicity, structure-metabolism, and computational molecular modeling studies with NAD(P)H:quinone oxidoreductase 1. Hassani M; Cai W; Holley DC; Lineswala JP; Maharjan BR; Ebrahimian GR; Seradj H; Stocksdale MG; Mohammadi F; Marvin CC; Gerdes JM; Beall HD; Behforouz M J Med Chem; 2005 Dec; 48(24):7733-49. PubMed ID: 16302813 [TBL] [Abstract][Full Text] [Related]
7. Cryptolepine analogues containing basic aminoalkyl side-chains at C-11: synthesis, antiplasmodial activity, and cytotoxicity. Lavrado J; Paulo A; Gut J; Rosenthal PJ; Moreira R Bioorg Med Chem Lett; 2008 Feb; 18(4):1378-81. PubMed ID: 18207399 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro evaluation of imidazole-based wakayin analogues. Hoang H; Huang X; Skibo EB Org Biomol Chem; 2008 Sep; 6(17):3059-64. PubMed ID: 18698463 [TBL] [Abstract][Full Text] [Related]
9. A novel class of in vivo active anticancer agents: achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065. Sato A; McNulty L; Cox K; Kim S; Scott A; Daniell K; Summerville K; Price C; Hudson S; Kiakos K; Hartley JA; Asao T; Lee M J Med Chem; 2005 Jun; 48(11):3903-18. PubMed ID: 15916443 [TBL] [Abstract][Full Text] [Related]
10. CB 1954: from the Walker tumor to NQO2 and VDEPT. Knox RJ; Burke PJ; Chen S; Kerr DJ Curr Pharm Des; 2003; 9(26):2091-104. PubMed ID: 14529407 [TBL] [Abstract][Full Text] [Related]
11. Aziridinyldinitrobenzamides: synthesis and structure-activity relationships for activation by E. coli nitroreductase. Helsby NA; Atwell GJ; Yang S; Palmer BD; Anderson RF; Pullen SM; Ferry DM; Hogg A; Wilson WR; Denny WA J Med Chem; 2004 Jun; 47(12):3295-307. PubMed ID: 15163209 [TBL] [Abstract][Full Text] [Related]
12. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties. Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551 [TBL] [Abstract][Full Text] [Related]
15. Sulfonyl-containing aldophosphamide analogues as novel anticancer prodrugs targeted against cyclophosphamide-resistant tumor cell lines. Jain M; Fan J; Baturay NZ; Kwon CH J Med Chem; 2004 Jul; 47(15):3843-52. PubMed ID: 15239662 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, analysis and biological evaluation of novel indolquinonecryptolepine analogues as potential anti-tumour agents. Le Gresley A; Gudivaka V; Carrington S; Sinclair A; Brown JE Org Biomol Chem; 2016 Mar; 14(11):3069-79. PubMed ID: 26893255 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor evaluation of analogues of the marine pyrroloiminoquinone tsitsikammamines. Rives A; Le Calvé B; Delaine T; Legentil L; Kiss R; Delfourne E Eur J Med Chem; 2010 Jan; 45(1):343-51. PubMed ID: 19897281 [TBL] [Abstract][Full Text] [Related]
18. Indolequinone antitumor agents: correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity. Beall HD; Winski S; Swann E; Hudnott AR; Cotterill AS; O'Sullivan N; Green SJ; Bien R; Siegel D; Ross D; Moody CJ J Med Chem; 1998 Nov; 41(24):4755-66. PubMed ID: 9822546 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for E. coli nitroreductase activation. Jiang Y; Han J; Yu C; Vass SO; Searle PF; Browne P; Knox RJ; Hu L J Med Chem; 2006 Jul; 49(14):4333-43. PubMed ID: 16821793 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumoral evaluation of indole alkaloid analogues containing an hexahydropyrrolo[1',2',3':1,9a,9]imidazo[1,2-a]indole skeleton. Ventosa-Andrés P; González-Vera JA; Valdivielso AM; Teresa García-López M; Herranz R Bioorg Med Chem; 2008 Oct; 16(20):9313-22. PubMed ID: 18818089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]